Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Core content updated with an operating-status notice and a version upgrade from v3.0.2 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-02T01:22:09.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    Update: version revision changed from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-30T13:16:05.000Z thumbnail image
  6. Check
    34 days ago
    Change Detected
    Summary
    Core content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.
    Difference
    0.2%
    Check dated 2025-09-23T09:46:52.000Z thumbnail image
  7. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' navigation element has been removed.
    Difference
    0.1%
    Check dated 2025-09-16T04:48:07.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-09T00:36:12.000Z thumbnail image
  9. Check
    55 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as detailed information on drug safety and counterfeit drugs. Notably, the drug trifluridine/tipiracil is highlighted, indicating a focus on its clinical relevance.
    Difference
    7%
    Check dated 2025-09-01T20:42:47.000Z thumbnail image

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.